12th October 2022
Bio-Techne brings together gold-standard spatial biology RNAscope™ ISH technology with exceptionally bright TSA Vivid™ Fluorophores to provide industry leading, highly-sensitive RNA detection for any gene, species, or tissue.
28th July 2022
Bio-Techne has signed an agreement under which it has acquired an exclusive license to commercialize the University of Dundee's BromoTag® system and will fund postdoctoral research at CeTPD.
16th March 2021
Bio-Techne subsidiary Tocris Bioscience, based in Bristol, UK, receives ISO 9001:2015 Quality Management Systems Certification.
6th November 2019
Bio-Techne has acquired a license from C4 Therapeutics to the new aTAG platform for selective degradation of specific proteins within cells.
10th December 2018
Bio-Techne has released two new GMP products, Y-27632 and CHIR 99021, for use in stem cell therapy development.
8th August 2018
Tocris has launched the first GMP small molecules for use as ancillary reagents (raw materials) in the further manufacture of stem cell therapies.
2nd April 2017
Tocris has launched new Janelia Fluor™ Dyes, which are bright and photostable and can be used in advanced imaging techniques.
13th December 2016
Tocris Bioscience has signed an agreement with Brigham and Women's Hospital, Boston (USA), to acquire an exclusive license for LDN 193189.
7th December 2016
Tocris Bioscience has announced a collaboration with the Chemical Probes Portal to help scientists find and purchase the best small molecule reagents for their research.
7th November 2016
Tocris Bioscience, part of the Biotechnology division of Bio-Techne, today announced the launch of its new compound library, Tocriscreen™ Plus.
7th March 2016
Tocris Bioscience today announced that it has relocated to a new 30,000 square foot premises located on the outskirts of Bristol, UK